IL15 and neoplasm: In this study, IL-15 DCs are shown to possess potent tumor antigen presentation function in combination with lytic potential against the classical NK cell target cell line K562, thus confirming the hypothesis that IL-15 DCs qualify for the designation of killer DCs.